Changes in glycoprotein IIb/IIIa inhibitor excess dosing with site-specific safety feedback in the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines (CRUSADE) initiative
Daniel W. Mudrick(OhioHealth), Karen P. Alexander(Clinical Research Institute), Anita Y. Chen(University of Rochester Medicine), E. Magnus Ohman(Office of Science), Eric D. Peterson, L. Kristin Newby(Duke University), W. Brian Gibler(University of Cincinnati), Matthew T. Roe(Clinical Research Institute)
Cited by 13
Related Papers
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
|Journal of the American College of Cardiology|2014|3.6k
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
|The Lancet|2018|1.8k
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease
|Journal of the American College of Cardiology|2016|1.6k